Terms: = Kidney tumors AND ATP1A1, P05023, MGC51750, MGC3285, ENSG00000163399, 476
51 results:
1. Cross-sectional analysis of cardiovascular disease and risk factors in patients with spondyloarthritis: a real-life evidence from biostar nationwide registry.
Duruöz MT; Bodur H; Ataman Ş; Gürer G; Akgül Ö; Çay HF; Çapkın E; Sezer İ; Rezvani A; Melikoğlu MA; Yağcı İ; Yurdakul FG; Göğüş FN; Kamanlı A; Çevik R; Altan L
Rheumatol Int; 2024 Apr; 44(4):631-642. PubMed ID: 38319376
[TBL] [Abstract] [Full Text] [Related]
2. Extracranial malignant rhabdoid tumors in children: high mortality even with the help of an aggressive clinical approach.
Xie S; Fang Y; Yang Y; Liu L; Bai J; Lin S; Zhang B; Fang Y
Eur J Pediatr; 2024 Feb; 183(2):557-567. PubMed ID: 38019286
[TBL] [Abstract] [Full Text] [Related]
3. Patients with metastatic renal cell carcinoma who receive immune-targeted therapy may derive survival benefit from nephrectomy.
Dong H; Cao Y; Jian Y; Lei J; Zhou W; Yu X; Zhang X; Peng Z; Sun Z
BMC Cancer; 2023 Oct; 23(1):943. PubMed ID: 37803307
[TBL] [Abstract] [Full Text] [Related]
4. Diagnostic value of machine learning-based computed tomography texture analysis for differentiating multiple myeloma from osteolytic metastatic bone lesions in the peripheral skeleton.
Özgül HA; Akin IB; Mutlu U; Balci A
Skeletal Radiol; 2023 Sep; 52(9):1703-1711. PubMed ID: 37014470
[TBL] [Abstract] [Full Text] [Related]
5. Organ Transplants From Deceased Donors With Primary Brain tumors and Risk of Cancer Transmission.
Greenhall GHB; Rous BA; Robb ML; Brown C; Hardman G; Hilton RM; Neuberger JM; Dark JH; Johnson RJ; Forsythe JLR; Tomlinson LA; Callaghan CJ; Watson CJE
JAMA Surg; 2023 May; 158(5):504-513. PubMed ID: 36947028
[TBL] [Abstract] [Full Text] [Related]
6. Clinical and economic burden of benign and malignant skin lesions in renal transplant recipients.
Thet Z; Lam AK; Pham T; Ng SK; Steel JC; Sawhney S; Arellano CT; Aung SY; Han T; Ranganathan D; John G; Pepito C; Rautenberg T; Khoo TK
Intern Med J; 2023 Nov; 53(11):2042-2049. PubMed ID: 36710434
[TBL] [Abstract] [Full Text] [Related]
7. Outcomes of palliative surgery for bone metastasis of metastatic renal cell carcinoma in the era of targeted therapy.
Hara H; Kawamoto T; Fukase N; Sawada R; Fujiwara S; Yahiro S; Miyamoto T; Terakawa T; Mifune Y; Hoshino Y; Kakutani K; Matsumoto T; Matsushita T; Niikura T; Kuroda R; Akisue T
Eur J Surg Oncol; 2023 May; 49(5):928-933. PubMed ID: 36463006
[TBL] [Abstract] [Full Text] [Related]
8. Telomere-related gene risk model for prognosis and drug treatment efficiency prediction in kidney cancer.
Li SC; Jia ZK; Yang JJ; Ning XH
Front Immunol; 2022; 13():975057. PubMed ID: 36189312
[TBL] [Abstract] [Full Text] [Related]
9. Factors affecting prognosis of the patients with severe hyponatremia.
Turkmen E; Karatas A; Altindal M
Nefrologia (Engl Ed); 2022; 42(2):196-202. PubMed ID: 36153916
[TBL] [Abstract] [Full Text] [Related]
10. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
[No Abstract] [Full Text] [Related]
11. A Clinical Decision Aid to Support Personalized Treatment Selection for Patients with Clinical T1 Renal Masses: Results from a Multi-institutional Competing-risks Analysis.
Psutka SP; Gulati R; Jewett MAS; Fadaak K; Finelli A; Legere L; Morgan TM; Pierorazio PM; Allaf ME; Herrin J; Lohse CM; Houston Thompson R; Boorjian SA; Atwell TD; Schmit GD; Costello BA; Shah ND; Leibovich BC
Eur Urol; 2022 Jun; 81(6):576-585. PubMed ID: 34862099
[TBL] [Abstract] [Full Text] [Related]
12. Camrelizumab plus Famitinib in Patients with Advanced or Metastatic Renal Cell Carcinoma: Data from an Open-label, Multicenter Phase II Basket Study.
Qu YY; Zhang HL; Guo H; Luo H; Zou Q; Xing N; Xia S; Sun Z; Zhang X; He C; Cai J; Zhang X; Wang Q; Ye DW
Clin Cancer Res; 2021 Nov; 27(21):5838-5846. PubMed ID: 34400414
[TBL] [Abstract] [Full Text] [Related]
13. Cytoreductive Nephrectomy Following Immunotherapy-Base Treatment in Metastatic Renal Cell Carcinoma: A Case Series and Review of Current Literature.
Dawsey SJ; Campbell SC; Ornstein MC
Curr Oncol; 2021 May; 28(3):1921-1926. PubMed ID: 34065284
[TBL] [Abstract] [Full Text] [Related]
14. Breast cancers observed in transplant patients in a single institution.
Anderson TL; Brandts HM; Gunderson T; Fazzio RT; Hunt KN; Heimbach JK; Glazebrook KN
Clin Imaging; 2021 Aug; 76():26-29. PubMed ID: 33548889
[TBL] [Abstract] [Full Text] [Related]
15. Oncologic outcomes and safety of percutaneous cryoablation for biopsy-proven renal cell carcinoma up to 4 cm in diameter: a prospective observational study.
Gobara H; Hiraki T; Iguchi T; Matsui Y; Sakurai J; Uka M; Tomita K; Komaki T; Kobayasi Y; Araki M; Watanabe T; Kanazawa S
Int J Clin Oncol; 2021 Mar; 26(3):562-568. PubMed ID: 33174078
[TBL] [Abstract] [Full Text] [Related]
16. Neutrophil-to-Lymphocyte Ratio Predicts Pathological Renal Sinus Fat Invasion in Renal Cell Carcinomas of ≤7 cm with Presumed Renal Sinus Fat Invasion.
Kim J; Park JS; Heo JE; Elghiaty A; Jang WS; Rha KH; Choi YD; Ham WS
Yonsei Med J; 2019 Nov; 60(11):1021-1027. PubMed ID: 31637883
[TBL] [Abstract] [Full Text] [Related]
17. Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS Trial.
Bracarda S; Bamias A; Casper J; Negrier S; Sella A; Staehler M; Tarazi J; Felici A; Rosbrook B; Jardinaud-Lopez M; Escudier B
Clin Genitourin Cancer; 2019 Jun; 17(3):e689-e703. PubMed ID: 31072748
[TBL] [Abstract] [Full Text] [Related]
18. Survival after a cancer diagnosis among solid organ transplant recipients in the United States.
D'Arcy ME; Coghill AE; Lynch CF; Koch LA; Li J; Pawlish KS; Morris CR; Rao C; Engels EA
Cancer; 2019 Mar; 125(6):933-942. PubMed ID: 30624768
[TBL] [Abstract] [Full Text] [Related]
19. Use of targeted therapy in patients with metastatic renal cell carcinoma: clinical and economic impact in a Canadian real-life setting.
Nazha S; Tanguay S; Kapoor A; Jewett M; Kollmannsberger C; Wood L; Bjarnason G; Heng D; Soulières D; Reaume N; Basappa N; Lévesque E; Dragomir A
Curr Oncol; 2018 Dec; 25(6):e576-e584. PubMed ID: 30607126
[TBL] [Abstract] [Full Text] [Related]
20. Combined assessment of low PGRMC1/positive atp1a1 levels has enhanced prognostic value for renal cell carcinoma.
He Y; Zhang P; Zhang D; Xia Z; Wang X; Deng S; Li H; Zhu H; Xu N; Liang S
Oncol Rep; 2018 Sep; 40(3):1467-1476. PubMed ID: 30015972
[TBL] [Abstract] [Full Text] [Related]
[Next]
